ArticleJournal of medicine and life2025

Modulation of metabolic syndrome components by oral semaglutide in hypothyroid-T2DM patients: a retrospective analysis.

Dana-Mihaela Tilici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.